EOG
46
3
SIG
43
5
COF
42
-2
CCI
23
-2
AES
37
-2
BBY
53
-3
DHI
33
-2
CNX
46
-3
GOOG
61
-4
AAPL
48
8
XRAY
23
-5
DVN
35
13
TSCO
50
2
VIX
66
11
PVH
40
-8
MA
44
-2
DGX
35
-2
AON
34
-2
PM
49
-7
SBUX
45
-3
EOG
46
3
SIG
43
5
COF
42
-2
CCI
23
-2
AES
37
-2
BBY
53
-3
DHI
33
-2
CNX
46
-3
GOOG
61
-4
AAPL
48
8
XRAY
23
-5
DVN
35
13
TSCO
50
2
VIX
66
11
PVH
40
-8
MA
44
-2
DGX
35
-2
AON
34
-2
PM
49
-7
SBUX
45
-3
Financhill
Back

NeoGenomics 10K Form

Sell
38

NEO
NeoGenomics

Last Price:
$14.75
Seasonality Move:
23.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-30 10Q NEO/NeoGenomics Quarterly
2024-02-20 10K NEO/NeoGenomics Annual
2023-11-06 10Q NEO/NeoGenomics Quarterly
2023-08-08 10Q NEO/NeoGenomics Quarterly
2023-05-09 10Q NEO/NeoGenomics Quarterly
2023-02-24 10K NEO/NeoGenomics Annual

Receive NEO News And Ratings

See the #1 stock for the next 7 days that we like better than NEO

NEO Financial Statistics

Sales & Book Value

Annual Sales: $591.6M
Cash Flow: $-1.6M
Price / Cash Flow: 0
Annual Sales: $7.09
Price / Book: 2.09

Profitability

EPS (TTM): -0.61000
Net Income (TTM): $-77.7M
Gross Margin: $244.6M
Return on Equity: -8.38%
Return on Assets: -4.69%

NeoGenomics Earnings Forecast

Key NeoGenomics Financial Ratios

  • The Gross Profit Margin over the past 24 years for NEO is 41.34%.
  • The Selling, General & Administrative Expenses for NEO have been equal to 53.06% of Gross Profit Margin.
  • The Research & Development expenses have been 4.62% of Revenue.
  • The Net Earning history of NEO is -14.87% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 11 years.

NeoGenomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NEO
CUSIP: 64049M
Website: neogenomics.com

Debt

Debt-to-Equity Ratio: 0.6
Current Ratio: 1.99
Quick Ratio: 1.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 38.87

NEO Technical Analysis vs Fundamental Analysis

Sell
38
NeoGenomics (NEO) is a Sell

Is NeoGenomics a Buy or a Sell?

  • NeoGenomics stock is rated a Sell
    The current NeoGenomics [NEO] share price is $14.77. The Score for NEO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.